Vanadium in diabetes: 100 years from Phase 0 to Phase I.
about
Impaired Acid Catalysis by Mutation of a Protein Loop Hinge Residue in a YopH Mutant Revealed by Crystal StructuresWhy Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical ReviewThe metal face of protein tyrosine phosphatase 1BCyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatmentInfluence of fructose and fatty-rich diet combined with vanadium on bone marrow cellsFAB, ESI and MALDI Mass Spectrometric methods in the study of metallo-drugs and their biomolecular interactions.Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1BCharacterisation of potential antidiabetic-related proteins from Pleurotus pulmonarius (Fr.) Quél. (grey oyster mushroom) by MALDI-TOF/TOF mass spectrometry.The Structural Basis of Action of Vanadyl (VO(2+)) Chelates in Cells.The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patientsTrace elements in glucometabolic disorders: an update.Spherical Oligo-Silicic Acid SOSA Disclosed as Possible Endogenous Digitalis-Like Factor.Vanadium speciation by XANES spectroscopy: a three-dimensional approach.Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study.Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans.A Comparative Study of Relationship between Micronutrients and Gestational DiabetesA coordination chemistry study of hydrated and solvated cationic vanadium ions in oxidation states +III, +IV, and +V in solution and solid state.Suppressive effect of orthovanadate on hepatic stellate cell activation and liver fibrosis in rats.14-Day Toxicity Studies of Tetravalent and Pentavalent Vanadium Compounds in Harlan Sprague Dawley Rats and B6C3F1/N Mice via Drinking Water Exposure.Characterization and cytotoxic effect of aqua-(2,2',2''-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells.The challenges of trafficking hydrolysis prone metals and ascidians as an archetype.Metal-based anti-diabetic drugs: advances and challenges.Selenium interactions and toxicity: a review. Selenium interactions and toxicity.An evidence-based systematic review of vanadium by the Natural Standard Research Collaboration.The discovery of vanadyl and zinc complexes for treating diabetes and metabolic syndromes.PTP1B: a simple enzyme for a complex world.Advances in research on the accumulation, redox behavior, and function of vanadium in ascidians.Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.Influence of Primary Ligands (ODA, TDA) on Physicochemical and Biological Properties of Oxidovanadium (IV) Complexes with Bipy and Phen as Auxiliary Ligands.Inhibition of human amylin fibril formation by insulin-mimetic vanadium complexes.Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements.Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?Serum Trace Elements and Electrolytes Are Associated with Fasting Plasma Glucose and HbA1c in Postmenopausal Women with Type 2 Diabetes Mellitus.Synthesis, Characterization, and Antibacterial Studies of Pd(II) and Pt(II) Complexes of Some Diaminopyrimidine Derivatives.Jeju ground water containing vanadium enhances antioxidant systems in human liver cells.VO(2+)-hydroxyapatite complexes as models for vanadyl coordination to phosphate in bone.Vanadyl bisacetylacetonate protects β cells from palmitate-induced cell death through the unfolded protein response pathway.
P2860
Q27653412-F2D8E1FD-3C11-4B61-A01C-E81E86920D71Q28068342-FE08F95F-F4DB-4FC2-8673-B27597F1B05FQ28074241-05EDD680-6728-4BAC-9517-93A968F4EFA4Q28652149-F14CA9B3-09DC-4B7F-9975-4A36A1C9FB31Q31128540-6ECDB71D-CA75-4895-A69A-5CA2AB013A1CQ33869892-4B25DB8C-A038-48DD-AAC6-C6B5806E734FQ34170125-E26F376C-609A-4100-B829-CAA503AF494BQ34177390-3B91C254-7269-40B1-825D-68B06EE158B1Q34180436-E33BCCD8-1E75-458D-9799-F6450D0E602CQ34262663-038A7B2B-B72A-4FB0-A33B-AD54D90866B6Q34272841-350E395F-6C01-4973-8B09-D625568A3B66Q34504189-2FB9E37D-3E98-4AB9-BCE4-695034EB0E23Q35005672-FAD02499-BB8E-4939-A476-723076A1602BQ35218165-EC4D565A-9BFC-4A48-A2FA-AADEB6FE8C36Q35220583-5FE27920-E5E4-4C8F-AB7C-2B0D49580F67Q35612899-46C72869-60DE-4B46-A619-54C63F9B5DDAQ35618949-BB9F4F31-3A45-47F8-AD2D-DD2A1CFD3E8EQ36231078-4AB464C2-46AE-419E-8BFF-D8F3628002EEQ36374573-AAE39831-85E7-4F0E-8687-9AA69DEFEE99Q37150782-1BE3E222-9CC3-47FE-81D9-0EF9A2B4E54CQ37540944-C8DC6BAD-85DE-4A38-82FB-39439BD1FD5EQ37703251-6BA0FB77-36B1-4A4D-A822-C1A031A6992EQ37853432-995F524F-86FA-47EF-A2E3-A4C93895EF21Q37900507-FFA0EED1-16A9-46D7-9AF3-3B1A83BF742DQ37931095-8599AF24-AB99-47FD-ABA0-B465EB8BF77EQ38034568-D8FD5FD7-6483-4EFB-BCF1-F73334A90814Q38089158-F4FDC7C2-BCBF-4EF8-B9E6-3B47F3CD4E86Q38123537-486D9600-07A6-42B0-B225-24CCAFC9523CQ38472399-516CC201-178B-46B8-A2D2-326065930B23Q38520262-D1AAF806-8C71-4B42-AB7E-CEA0243C2140Q38780536-16FCE839-7F35-4B1E-9A72-4EBDA037F52AQ39006181-6D229BC4-614A-4372-A7BE-C7B6B85D00A5Q39135929-56B2688D-FC29-46C5-AF31-CC67D0C67399Q39209457-6A7ADB2F-AA39-4E0A-B373-7E45F0E148C3Q39237165-DD233F4F-3FBC-44C7-854F-13DD9D1D3C3EQ39279059-646D3C3D-1AA9-4566-8C2A-29F7D4A162C9Q39376595-C857987E-FCBD-47DC-AC30-105AC105A28EQ39434278-C69DDB04-AD69-49FA-A5A9-70275AF5C432Q39471207-E1F21174-FF4E-4A63-9B91-BBD589B7ED6BQ39554713-DE8C040E-027D-4471-87D6-320956528054
P2860
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@ast
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@en
type
label
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@ast
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@en
prefLabel
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@ast
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@en
P1476
Vanadium in diabetes: 100 years from Phase 0 to Phase I.
@en
P2093
Katherine H Thompson
P304
P356
10.1016/J.JINORGBIO.2006.08.016
P50
P577
2006-09-07T00:00:00Z